ViewRay Inc. received federal regulatory clearance to begin commercializing its MRI-based technology to deliver radiation therapy to cancer patients.
The Oakwood, Ohio-based company’s imaging device received clearance under the Food & Drug Administration’s 510(k) program for medical devices in January, according to the agency.
CEO Greg Ayres declined comment through a spokeswoman.